[
  {
    "ts": null,
    "headline": "Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026",
    "summary": "WALTHAM, Mass., February 05, 2026--Revvity, Inc. (NYSE: RVTY) announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows. Making their debut at the conference in Boston, February 7-11, are the Opera Phenix OptIQ™ high-content screening system, the EnVision Nexus™ One multimode plate reader, and the AssayMate™ workstation, alongside other recently introduced solutions spanning sample preparation,",
    "url": "https://finnhub.io/api/news?id=7907017f28e8a6118aeb2057d8ae22d2f18842096ee12ec97aaefa9780eb1411",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770296400,
      "headline": "Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026",
      "id": 138363797,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RVTY",
      "source": "Yahoo",
      "summary": "WALTHAM, Mass., February 05, 2026--Revvity, Inc. (NYSE: RVTY) announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows. Making their debut at the conference in Boston, February 7-11, are the Opera Phenix OptIQ™ high-content screening system, the EnVision Nexus™ One multimode plate reader, and the AssayMate™ workstation, alongside other recently introduced solutions spanning sample preparation,",
      "url": "https://finnhub.io/api/news?id=7907017f28e8a6118aeb2057d8ae22d2f18842096ee12ec97aaefa9780eb1411"
    }
  }
]